Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00222417|
Recruitment Status : Unknown
Verified June 2012 by University Hospital of North Norway.
Recruitment status was: Active, not recruiting
First Posted : September 22, 2005
Last Update Posted : June 21, 2012
|Condition or disease||Intervention/treatment||Phase|
|Otosclerosis Tympanic Membrane Perforation||Procedure: myringoplasty Procedure: Stapes surgery||Phase 2 Phase 3|
|Study Type :||Observational|
|Actual Enrollment :||44 participants|
|Observational Model:||Case Control|
|Official Title:||Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease|
|Study Start Date :||September 2002|
|Estimated Study Completion Date :||December 2014|
Patients subject to myringoplasty for tympanic membrane perforations.
Myringoplasty is an operative procedure to close tympanic membrane perforations.
Patients subject to stapes surgery
Procedure: Stapes surgery
Operative procedure aimed to replace non-functioning stapes with a synthetic prosthesis
- Post-operative hearing threshold level [ Time Frame: 1 year ]Pure tone audiometry, speech audiometry, otoacoustic emissions
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00222417
|ENT-department, University Hospital of Tromsø|
|Tromsø, Troms, Norway, 9038|
|Principal Investigator:||Niels C Stenklev, MD, PhD||ENT-department, University of Tromsø, 9038 Tromsø, Norway|